EurekAlert! -
26 Mar 2020 06:00
(H. Lee Moffitt Cancer Center & Research Institute) Researchers at Moffitt Cancer Center are trying to identify alternative strategies to treat non-small cell lung cancer (NSCLC). In a new article published online in Scientific Reports, they highlight how targeting the histone deacetylase HDAC11 may be a novel therapeutic strategy for NSCLC.
Share this Article